Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6Metastatic Castration-resistant Prostate Cancer 2PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1Kidney Neoplasms 1Glioma 1Glioblastoma 1Clear-cell metastatic renal cell carcinoma 1Astrocytoma 1

Interventions

cabozantinib 4Nivolumab 2Ipilimumab 2zimberelimab 1temsirolimus 1salicylhydroxamic acid 1orellanine 1atezolizumab 1Surveys and Questionnaires 1Ropivacaine 1Pluvicto 1Methods 1Health Promotion 1Granulocyte-Macrophage Colony-Stimulating Factor 1Genetic Counseling 1Erlotinib Hydrochloride 1Educational Status 1Early Intervention, Educational 1Docetaxel 1Dacarbazine 1Counseling 1Blood Component Removal 1Axitinib 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Pluvicto × 30 days × Clear all
NCT06783348 2026-06-04

RENALUT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting
48 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡